To identify responsible factors that are involved in oncogenic signaling of HR positive breast cancer cells, we performed Co-IP with HA-PGRMC1 followed by mass spectrometry and identified PHB1 and PHB2 as possible PGRMC1 interaction partners upon treatment with NET. The gene discussed is PGRMC1; the disease is breast carcinoma.